Target intelligence / Profile preview

DNA-directed RNA polymerase subunit beta (bacterial) (RNAP β)

Target
RNAP β
Molecular classification
Enzyme, Transcription factor (as a core part of multisubunit RNA polymerase), Other (catalytic core of RNA polymerase complex)
01

Overview

The DNA-directed RNA polymerase subunit beta is a core catalytic subunit of the bacterial DNA-dependent RNA polymerase (RNAP), responsible for RNA synthesis from a DNA template[2][4][5]. Encoded by the rpoB gene, the β subunit forms part of the enzymatic center, directly contributing to the catalysis of ribonucleotide polymerization and binding of nucleic acids[2][5][7]. The β subunit is integral to the core enzyme's structure, associating with β', two α subunits, and ω to form the RNAP core, which associates with sigma factors for promoter recognition[4][2][5]. The β subunit is the main binding site for rifampin and other antibiotics, making it a critical drug target in antimicrobial therapy[3][4]. Mutations in the β subunit confer resistance to rifampin, an important consideration in the treatment of tuberculosis and other bacterial infections[2][4].

Other names
RNA polymerase beta subunitRNAP β subunitrpoB gene productBacterial RNA polymerase β
02

Mechanism of action

Inhibition of RNA synthesis by binding β subunit and blocking the transcription initiation or elongation process (e.g., rifampin binds β subunit to inhibit RNA chain elongation) - Allosteric inhibition of transcription initiation or elongation (drug-dependent)

03

Biological functions

Gene transcription (synthesis of RNA from DNA template)Catalytic center for RNA synthesisMaintains nucleic acid scaffold (during transcription)
04

Disease associations

Infection (critical for bacterial viability; major target in antibacterial therapy)
05

Safety considerations

Rapid development of drug resistance (notably rifampin resistance via rpoB mutations)Cross-reactivity with mitochondrial RNA polymerase (minimal, but possible with certain inhibitors)Essentiality for bacterial survival means inhibition can be microbe-selective but may affect microbiome balance
06

Interacting drugs

Rifampin (rifampicin)

5 more in the full profile.

Beyond the preview

Go deeper on DNA-directed RNA polymerase subunit beta (bacterial) (RNAP β).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase subunit beta (bacterial) (RNAP β).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call